Compare Federal Laws, Regulations, and Policies in Science and Security
21 September 2022 by CITI Program

The Council on Governmental Relations (COGR) has released version two of their research security comparison chart, summarizing and comparing federal laws, regulations, and policies. The…

Presidential Order on Advancing Biotech and Biomanufacturing Innovation
21 September 2022 by CITI Program

The President of United States of America has issued an executive order to promote a sustainable, safe, and secure bioeconomy. Thirteen sections detail a wide-range…

What CITI Program is Reading – September 20th, 2022
20 September 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

CITI Program’s September 2022 Media Playlist – Part 1
20 September 2022 by CITI Program

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…

How to Satisfy NSPM-33 Training Requirements
20 September 2022 by CITI Program

The National Security Presidential Memorandum 33 (NSPM-33) is an increasingly discussed topic in academia. The National Science and Technology Council’s (NTSC) Implementation Guide highlights four…

See the FDA’s Updated Guidance on Compounding Animal Drugs
8 September 2022 by CITI Program

The U.S. Food and Drug Administration (FDA) issued an update guidance, titled Compounding Animal Drugs from Bulk Drug Substances. This guidance is a continuation of…

What CITI Program is Reading – September 7th, 2022
7 September 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

HHS Requests Input on Public Health Service Policies on Research Misconduct
2 September 2022 by CITI Program

The U.S. Department of Health and Human Services (HHS), Office of Research Integrity is seeking input from individuals, research funding agencies, institutional officials, organizations, institutions,…

FDA Authorizes Bivalent COVID-19 Vaccines for Use as a Booster Dose
1 September 2022 by CITI Program

The U.S. Food and Drug Administration (FDA) has approved bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines as a single booster dose. See the…

What CITI Program is Reading – August 30th, 2022
30 August 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

CITI Program’s August 2022 Media Playlist – Part 3
26 August 2022 by CITI Program

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…

Revised FDA Draft Guidance on Charging for Investigational Drugs
23 August 2022 by CITI Program

The U.S. Food and Drug Administration (FDA) issued a revised draft guidance, entitled Charging for Investigational Drugs Under an IND Questions and Answers. When finalized,…